Status:
COMPLETED
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
Lead Sponsor:
SWOG Cancer Research Network
Collaborating Sponsors:
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Conditions:
Leukemia
Myelodysplastic Syndromes
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. ...
Detailed Description
Primary objective: \* Maintain and expand a database of cytogenetic information on leukemia patients. Other objectives as funding permits: * Determine the frequency and prognostic significance of c...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Registered on one of the following Southwest Oncology Group treatment protocols:
- SWOG-8326, SWOG-8600, SWOG-8612, SWOG-9034, SWOG-9108, OR any new leukemia protocol approved as of 1990
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
July 1 1991
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
3341 Patients enrolled
Trial Details
Trial ID
NCT00996047
Start Date
July 1 1991
End Date
January 1 2012
Last Update
March 6 2015
Active Locations (280)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States, 36608
2
Providence Cancer Center
Anchorage, Alaska, United States, 99508
3
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States, 85724-5024
4
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States, 72903